TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Nixonnoxin AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,422
|
4,049
|
3,649 |
Financial expenses |
0
![]() |
0
|
3 |
Earnings before taxes |
2,152
|
3,721
|
2,610 |
EBITDA |
1,795
|
3,718
|
2,611 |
Total assets |
22,425
|
21,256
|
20,276 |
Current assets |
15,662
|
14,527
|
12,976 |
Current liabilities |
523
|
606
|
394 |
Equity capital |
20,790
|
19,611
|
18,877 |
- share capital |
34
|
33
|
36 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
92.7%
|
92.3%
|
93.1% |
Turnover per employee |
1,711
|
2,024
|
1,824 |
Profit as a percentage of turnover |
62.9%
|
91.9%
|
71.5% |
Return on assets (ROA) |
9.6%
|
17.5%
|
12.9% |
Current ratio |
2994.6%
|
2397.2%
|
3293.4% |
Return on equity (ROE) |
10.4%
|
19.0%
|
13.8% |
Change turnover |
-649
|
696
|
-1,306 |
Change turnover % |
-16%
|
21%
|
-26% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.